Aarey Drugs Allots 11.5 Lakh Shares On Warrant Conversion For Rs5.5 Crore

Board allotted 11.5L equity shares at Rs63.80 on warrant conversion on receipt of Rs5.50Cr from promoter and public allottees. Paid-up capital rises to 3.19Cr shares; 14.8L warrants remain. Second tranche after 23.7L converted in August, taking total to 35.2L of 50L. Mainly public holders this time after promoter-only first tranche, aiding working-capital funding runway. Conversion brings cash but dilutes equity; 14.8L overhang remains with 18-month window from May 2025 nearing end. Use of proceeds not detailed in filing.